Business Description
Mankind Pharma Ltd
ISIN : INE634S01028
Description
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 13.11 | |||||
Equity-to-Asset | 0.76 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | 0.08 | |||||
Interest Coverage | 68.34 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 23.77 | |||||
Beneish M-Score | -1.28 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Future 3-5Y Total Revenue Growth Rate | 19.39 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 42.14 | |||||
9-Day RSI | 39.82 | |||||
14-Day RSI | 42.89 | |||||
6-1 Month Momentum % | 29.21 | |||||
12-1 Month Momentum % | 71.29 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.66 | |||||
Quick Ratio | 1.94 | |||||
Cash Ratio | 1.11 | |||||
Days Inventory | 220.1 | |||||
Days Sales Outstanding | 39.42 | |||||
Days Payable | 148.71 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | 0.39 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 68.68 | |||||
Operating Margin % | 20.91 | |||||
Net Margin % | 18.26 | |||||
FCF Margin % | -18.06 | |||||
ROE % | 18.51 | |||||
ROA % | 14.15 | |||||
ROIC % | 18.13 | |||||
ROC (Joel Greenblatt) % | 43.2 | |||||
ROCE % | 22.39 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 62.25 | |||||
PE Ratio without NRI | 62.25 | |||||
PS Ratio | 11.37 | |||||
PB Ratio | 10.64 | |||||
Price-to-Tangible-Book | 13.36 | |||||
Price-to-Operating-Cash-Flow | 97.48 | |||||
EV-to-EBIT | 47.24 | |||||
EV-to-EBITDA | 40.78 | |||||
EV-to-Revenue | 11.08 | |||||
EV-to-FCF | -61.36 | |||||
Price-to-Graham-Number | 5.61 | |||||
Price-to-Net-Current-Asset-Value | 29.96 | |||||
Earnings Yield (Greenblatt) % | 2.12 | |||||
FCF Yield % | -1.59 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Mankind Pharma Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 78,936.754 | ||
EPS (TTM) (₹) | 35.954 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 42.89 | ||
14-Day ATR (₹) | 74.722844 | ||
20-Day SMA (₹) | 2315.555 | ||
12-1 Month Momentum % | 71.29 | ||
52-Week Range (₹) | 1242 - 2490 | ||
Shares Outstanding (Mil) | 400.59 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Mankind Pharma Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Mankind Pharma Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Mankind Pharma Ltd Frequently Asked Questions
What is Mankind Pharma Ltd(NSE:MANKIND)'s stock price today?
When is next earnings date of Mankind Pharma Ltd(NSE:MANKIND)?
Does Mankind Pharma Ltd(NSE:MANKIND) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |